Review
Biochemistry & Molecular Biology
Ruxandra Florentina Ionescu, Robert Mihai Enache, Sanda Maria Cretoiu, Bogdan Severus Gaspar
Summary: This article summarizes the recent findings on the correlation between gestational diabetes mellitus (GDM) and dysbiosis, as well as the prevention and treatment methods. The most common changes in the microbiome of GDM patients are an increase in Firmicutes phylum or a decrease in Bacteroidetes and Actinobacteria phyla. Gut dysbiosis persists postpartum and affects the development of newborns. Probiotic supplementation and regular physical activity have strong evidence in controlling blood glucose levels.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Medicine, General & Internal
Emilia Sawicka-Smiarowska, Kinga Bondarczuk, Witold Bauer, Magdalena Niemira, Anna Szalkowska, Justyna Raczkowska, Miroslaw Kwasniewski, Ewa Tarasiuk, Marlena Dubatowka, Magda Lapinska, Malgorzata Szpakowicz, Zofia Stachurska, Anna Szpakowicz, Pawel Sowa, Andrzej Raczkowski, Marcin Kondraciuk, Magdalena Gierej, Joanna Motyka, Jacek Jamiolkowski, Mateusz Bondarczuk, Malgorzata Chlabicz, Jolanta Bucko, Marcin Kozuch, Slawomir Dobrzycki, Jerzy Bychowski, Wlodzimierz Jerzy Musial, Adrian Godlewski, Michal Ciborowski, Attila Gyenesei, Adam Kretowski, Karol Adam Kaminski
Summary: Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. New factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated. CAD is associated with altered gut microbiome composition and function, including changes in Firmicutes/Bacteroidetes ratio and alpha-beta biodiversity.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Ophthalmology
Rehana Khan, Abhishek Sharma, Raghul Ravikumar, Avani Parekh, Ramyaa Srinivasan, Ronnie Jacob George, Rajiv Raman
Summary: The B/F ratio in diabetic patients may be a potential biomarker for the development of sight-threatening diabetic retinopathy, but no significant differences in gut microbial abundance for any specific phylum were found between the control and diseased population.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
(2021)
Review
Microbiology
Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri
Summary: The composition of gut microbiota is crucial for nutrient metabolism, mucosal barrier function, immunomodulation, and defense against pathogens. Disruptions in the gut microbiome may lead to the loss of beneficial bacteria and an increase in potentially harmful bacteria, contributing to the development and complications of liver diseases. Treatment options that improve gut dysbiosis may be beneficial for patients with liver disease.
Article
Agriculture, Dairy & Animal Science
Stella Agradi, Paola Cremonesi, Laura Menchetti, Claudia Balzaretti, Marco Severgnini, Federica Riva, Bianca Castiglioni, Susanna Draghi, Alessia Di Giancamillo, Marta Castrica, Daniele Vigo, Silvia Clotilde Modina, Valentina Serra, Alda Quattrone, Elisa Angelucci, Grazia Pastorelli, Giulio Curone, Gabriele Brecchia
Summary: BC is a nutraceutical that can modulate intestinal microbiota. This study investigates the effects of BC diet supplementation on luminal and mucosa-associated microbiota in the jejunum, caecum, and colon of rabbits. Significant differences were found in the microbial composition of the three groups, especially in the caecum and colon of the 2.5% BC group. A functional prediction has revealed several altered pathways in BC groups, with particular reference to amino acids and lactose metabolism. Findings suggest that BC supplementation could positively affect the intestinal microbiota.
Review
Microbiology
Noora Alhajri, Rubiya Khursheed, Mohammad Taher Ali, Tareq Abu Izneid, Oumaima Al-Kabbani, Mahdia B. Al-Haidar, Fatima Al-Hemeiri, Mohamed Alhashmi, Faheem Hyder Pottoo
Summary: The intestinal microbial ecosystem plays a critical role in the development and prevention of cardiovascular diseases (CVDs) and other metabolic disorders. Imbalances in gut microbiota composition have been linked to the development of new CVDs, highlighting the importance of understanding the gut-host interaction for disease management.
Article
Microbiology
Akarsh Mathrani, Louise W. Lu, Ivana R. Sequeira-Bisson, Marta P. Silvestre, Michael Hoggard, Daniel Barnett, Mikael Fogelholm, Anne Raben, Sally D. Poppitt, Michael W. Taylor
Summary: Obesity-related metabolic diseases, such as type 2 diabetes, are prevalent worldwide. Ethnicity plays a role in susceptibility to these diseases, and the gut microbiota may also have an influence. This study compared the fecal microbiota of European-ancestry and Chinese-ancestry cohorts with overweight and prediabetes in New Zealand, revealing significant microbiota differences between the ethnicities.
FRONTIERS IN MICROBIOLOGY
(2023)
Article
Nutrition & Dietetics
Martha Alejandra Chavoya-Guardado, Edgar Manuel Vasquez-Garibay, Sandra Luz Ruiz-Quezada, Maria Ines Ramirez-Cordero, Alfredo Larrosa-Haro, Jorge Castro-Albarran
Summary: This study found that the adiposity of women before pregnancy and during lactation is associated with the abundance of Bacteroidetes and Actinobacteria in human milk. This finding reveals a relationship between the microbiota of human milk and the mother's obesity status.
Article
Endocrinology & Metabolism
Filippo Biscarini, Giulia Masetti, Ilaria Muller, Hedda Luise Verhasselt, Danila Covelli, Giuseppe Colucci, Lei Zhang, Mohd Shazli Draman, Onyebuchi Okosieme, Pete Taylor, Chantal Daumerie, Maria-Cristina Burlacu, Michele Marino, Daniel George Ezra, Petros Perros, Sue Plummer, Anja Eckstein, Mario Salvi, Julian R. Marchesi, Marian Ludgate
Summary: This study compared the fecal microbiota in patients with hyperthyroidism caused by Graves disease (GD) and varying severity of Graves orbitopathy (GO) with healthy controls. The results showed an increase in Actinobacteria and a decrease in Bacteroidetes in GD/GO patients compared to controls. A higher Firmicutes to Bacteroidetes ratio was observed in GD/GO. Longitudinal analysis revealed a correlation between the presence of certain bacteria (Clostridiales) at diagnosis and the persistence of thyroid antibodies even after antithyroid drug treatment.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2023)
Article
Urology & Nephrology
Agni Nhirmal Kumar Sugurmar, Rozita Mohd, Shamsul Azhar Shah, Hui-min Neoh, Rizna Abdul Cader
Summary: While no significant differences were found in OTU and alpha diversity between IgAN patients in remission and healthy controls, there were differences at the phylum level between the two groups. Additionally, alpha diversity increased with increasing CKD stage.
Article
Nutrition & Dietetics
Hye Rim Kim, Eunsol Seo, Seyeon Oh, MinYeong Seo, Kyunghee Byun, Byung-Yong Kim
Summary: This study demonstrates that multi-strain probiotic treatment can alleviate obesity induced by high-carbohydrate diet, modulating the expression of genes related to fat composition, fat metabolism, and thermogenesis. It also improves the levels of obesity-related hormones and reverses the Firmicutes/Bacteroidetes ratio in the gut microbiota.
Article
Microbiology
Claudia Munoz Yanez, Alejandra Mendez Hernandez, Alondra Martinez Sandoval, Maria Aurora Maravilla Dominguez, Soraya Amali Zavaleta Muniz, Janeth Oliva Guangorena Gomez
Summary: The study found that the prevalence of Blastocystis in healthy subjects was 47.0% and 65.48% in subjects with metabolic disease. The most common subtype overall was ST3 (28.38%), followed by ST1, ST4, ST5, ST7, and ST2. The low Firmicutes/Bacteroidetes ratio was associated with the prevalence of Blastocystis, and certain subtypes showed an association with this ratio as well. The predatory role of Blastocystis over the Firmicutes phylum was observed in both cohorts, suggesting a potential beneficial effect on the Bacteroidetes group.
Article
Agricultural Engineering
Roent Dune A. Cayetano, Jungsu Park, Gi-Beom Kim, Ju-Hyeong Jung, Sang-Hyoun Kim
Summary: Bioaugmentation with hydrolytic bacteria and Clostridium sp. enhanced methane conversion of waste-activated sludge, changing the main methanogenic pathway and microbial species. Increased expression of hydrolases was found to play a key role in improving methane conversion efficiency through bioaugmentation.
BIORESOURCE TECHNOLOGY
(2021)
Review
Health Care Sciences & Services
Irina N. Grigor'eva
Summary: Obesity is a major risk factor for developing gallstone disease, possibly related to alterations in the gut microbiota. Studies on the gut microbiota in patients with GSD have shown significant changes in specific bacterial phyla. The impact of GSD on microbial diversity and the Firmicutes/Bacteroidetes ratio remains unclear.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Review
Gastroenterology & Hepatology
Esther Caparros, Reiner Wiest, Michael Scharl, Gerhard Rogler, Ana Gutierrez Casbas, Bahtiyar Yilmaz, Marcin Wawrzyniak, Ruben Frances
Summary: This review delves into the modification of the gut microbiota cluster network during CD progression and discusses how this shift compromises the gut barrier integrity, allowing the translocation of microbes and their products. It also retraces gut microbiota dysbiosis interactions with the main pathophysiologic factors of CD, providing insights on genetic background, immune inflammatory processes, and potential benefits of targeting a specific gut microbiota.
Article
Gastroenterology & Hepatology
Vincent Wai-Sun Wong, Won Young Tak, George Boon Bee Goh, Pin-Nan Cheng, Eric J. Lawitz, Zobair M. Younossi, Raj Vuppalanchi, Ziad Younes, Naim Alkhouri, Lulu Wang, Jialuo Liu, Kathryn Kersey, Robert P. Myers, Stephen A. Harrison, Zachary Goodman, Michael Trauner, Manuel Romero-Gomez, Quentin M. Anstee, Mindie H. Nguyen, Takeshi Okanoue
Summary: This study evaluated the performance of noninvasive tests in diagnosing advanced fibrosis due to NASH in white and Asian patients, and found that these tests performed similarly in both groups. However, the sensitivities of NFS, FIB-4, and ELF were low in white and Asian patients younger than 40 years.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Article
Gastroenterology & Hepatology
Manuel Romero-Gomez, Rocio Aller, Javier Ampuero, Conrado Fernandez Rodriguez, Salvador Augustin, Raquel Latorre, Jesus Rivera-Esteban, Belen Martinez Urroz, Luisa Gutierrez Garcia Maria, Sonia Alonso Lopez, Agustin Albillos, Marta Hernandez, Isabel Graupera, Salvador Benlloch, Antonio Olveira, Javier Crespo, Jose Luis Calleja
GASTROENTEROLOGIA Y HEPATOLOGIA
(2023)
Article
Gastroenterology & Hepatology
Rohit Loomba, Daniel Q. Huang, Arun J. Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J. Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S. Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, Manal F. Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M. Younossi, Robert P. Myers
Summary: In patients with non-alcoholic steatohepatitis (NASH), liver stiffness (LS) measured by vibration-controlled transient elastography (VCTE) can predict the progression of cirrhosis and the risk of liver decompensation.
Article
Gastroenterology & Hepatology
Jiaxu Liang, Javier Ampuero, Javier Castell, Qiong Zhang, Sijia Zhang, Yong Chen, Manuel Romero-Gomez
Summary: Hepatocellular carcinoma (HCC) is a major public health problem worldwide and is closely related to liver fibrosis. Magnetic resonance elastography (MRE) has emerged as a non-invasive technique with excellent diagnostic accuracy for assessing liver fibrosis and tumor stiffness. Recent studies have shown that MRE has several novel clinical applications in HCC management, including predicting HCC development, differentiating between benign/malignant liver lesions and HCC pathological grades, assessing treatment response, and predicting recurrence after treatment. However, some findings are controversial. This review summarizes the novel applications of MRE in HCC patients and discusses their limitations and future advancement.
ANNALS OF HEPATOLOGY
(2023)
Article
Gastroenterology & Hepatology
Beatriz Mateos-Munoz, Maria Buti, Inmaculada Fernandez Vazquez, Marta Hernandez Conde, Vanesa Bernal-Monterde, Fernando Diaz-Fontenla, Rosa Maria Morillas, Luisa Garcia-Buey, Ester Badia, Mireia Miquel, Alberto Amador-Navarrete, Sergio Rodriguez-Tajes, Lucia Ramos-Merino, Antonio Madejon, Montserrat Garcia-Retortillo, Juan Ignacio Arenas, Joaquin Cabezas, Jesus Manuel Gonzalez Santiago, Conrado Fernandez-Rodriguez, Patricia Cordero, Moises Diago, Antonio Mancebo, Alberto Pardo, Manuel Rodriguez, Elena Hoyas, Jose Javier Moreno, Juan Turnes, Miguel Angel Simon, Cristina Marcos-Fosch, Jose Luis Calleja, Rafael Banares, Sabela Lens, Javier Garcia-Samaniego, Javier Crespo, Manuel Romero-Gomez, Francisco Gea, Enrique Rodriguez de Santiago, Santiago Moreno, Agustin Albillos
Summary: Compared to entecavir, tenofovir hydroxyl fumarate/emtricitabine plays a protective role in the severity of COVID-19 in patients with chronic hepatitis B.
DIGESTIVE DISEASES AND SCIENCES
(2023)
Article
Gastroenterology & Hepatology
Zobair M. Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S. Hamid, Mohamed El-Kassas, Wah Kheong Chan, Ajay K. Duseja, Stuart C. Gordon, Yuichiro Eguchi, Vasily A. Isakov, Stuart K. Roberts, Jian-Gao Fan, Ashwani K. Singal, Manuel Romero-Gomez, Aijaz Ahmed, Janus Ong, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Summary: Chronic hepatitis B (CHB) infection is a common cause of cirrhosis and liver cancer worldwide. The Global Liver Registry is being used to assess the clinical and patient-reported outcomes (PROs) of CHB patients from different regions. The study included 1818 CHB patients from 15 countries, with varying rates of advanced fibrosis. HBV subjects from the Middle East/North Africa had the lowest PRO scores, while those from Southeast/East and South Asia had the highest. Factors associated with PRO impairment in CHB patients included advanced fibrosis, non-hepatic comorbidities, and female sex.
JOURNAL OF VIRAL HEPATITIS
(2023)
Review
Gastroenterology & Hepatology
Dan Dumitrascu, Igor Bakulin, Annalisa Berzigotti, Marilia Cravo, Laura Gombosova, Milan Lukas, Anna Pietrzak, Jose Maria Remes-Troche, Manuel Romero-Gomez, Mercedes Amieva Balmori, Tiago Curdia Goncalves, Lamine Hamzaoui, Radovan Juricek, Leticia Moreira, Katarzyna Neubauer, Teodora Surdea-Blaga, Igor N. Tikhonov, Jan Trna, Gianluca Ianiro, Francesca Romana Ponziani, Antonio Gasbarrini
Summary: Various environmental factors can lead to gut microbial imbalance and the development of diseases. Hepatic encephalopathy, irritable bowel syndrome, and diverticular disease are all related to dysfunction of the gut-liver-brain axis, but the pathophysiology differs for each condition.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
(2023)
Article
Gastroenterology & Hepatology
Rocio Munoz-Hernandez, Sheila Gato, Antonio Gil-Gomez, Rocio Aller, Angela Rojas, Laura Moran, Javier Gallego, Elena Blazquez-Lopez, Rocio Gallego-Duran, Rocio Montero-Vallejo, Vanessa Garcia-Fernandez, Douglas Maya-Miles, Maria del C. Rico, Francisco J. Cubero, Javier Vaquero, Javier Ampuero, Rafael Banares, Manuel Romero-Gomez
Summary: This study evaluated the circulating AV+ EpCAM+ CD133+ EVs as a potential biomarker for the transition from simple steatosis to steatohepatitis. The results showed that these EVs increased during disease progression in both mouse models and clinical validation. Therefore, EpCAM+ CD133+ EVs hold promise as a non-invasive biomarker for evaluating and managing NAFLD patients.
LIVER INTERNATIONAL
(2023)
Article
Gastroenterology & Hepatology
Ares Villagrasa, Virginia Hernandez-Gea, Ramon Bataller, Alvaro Giraldez, Bogdan Procopet, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibanez-Samaniego, Agustin Albillos, Christophe Bureau, Jonel Trebicka, Elba Llop, Wim Laleman, J. M. Palazon, Jose Castellote, Susana L. Rodrigues, Lise N. Gluud, Carlos Ferreira, Nuria Canete, Manuel Rodriguez, Arnulf L. Ferlitsch, Jose Mundi, Henning Gronbaek, Manuel Hernandez-Guerra, Romano Sassatelli, Alessandra Dell'Era, Marco G. Senzolo, Juan Abraldes, Alexander Zipprich, Meritxell Casas, Helena Masnou, Massimo Primignani, Aleksander Krag, Gilberto Silva-Junior, Manuel Romero-Gomez, Marcel A. Tantau, Maria Guardascione, Edilmar Alvarado, Marika Rudler, Rafael Banares, Javier A. Martinez, Marie Robic, Christian L. Jansen, Jose Calleja, Frederik Nevens, Jaime Bosch, Meritxell C. Ventura-Cots, Juan Garcia-Pagan, Joan Genesca
Summary: This study aimed to assess the prevalence of alcohol-related hepatitis (AH) in patients with variceal bleeding and compare the clinical outcomes of AH patients with other alcohol-related liver disease (ALD) phenotypes and viral cirrhosis. The results showed that AH patients had more complications and abstinent ALD patients had higher survival rates compared to other groups.
LIVER INTERNATIONAL
(2023)
Article
Gastroenterology & Hepatology
Dan-Qin Sun, Giovanni Targher, Christopher D. Byrne, David C. Wheeler, Vincent Wai-Sun Wong, Jian-Gao Fan, Herbert Tilg, Wei-Jie Yuan, Christoph Wanner, Xin Gao, Michelle T. Long, Mehmet Kanbay, Mindie H. Nguyen, Sankar D. Navaneethan, Yusuf Yilmaz, Yuli Huang, Rino A. Gani, Pierluigi Marzuillo, Jerome Boursier, Huijie Zhang, Chan-Young Jung, Jin Chai, Luca Valenti, George Papatheodoridis, Giovanni Musso, Yu-Jun Wong, Mohamed El-Kassas, Nahum Mendez-Sanchez, Silvia Sookoian, Michael Pavlides, Ajay Duseja, Adriaan G. Holleboom, Junping Shi, Wah-Kheong Chan, Yasser Fouad, Junwei Yang, Sombat Treeprasertsuk, Helena Cortez-Pinto, Masahide Hamaguchi, Manuel Romero-Gomez, Mamun Al Mahtab, Ponsiano Ocama, Atsushi Nakajima, Chunsun Dai, Mohammed Eslam, Lai Wei, Jacob George, Ming-Hua Zheng
Summary: A multidisciplinary panel of 50 international experts reached a consensus on the link between MAFLD and CKD using a Delphi-based approach. This consensus statement provides guidance on the epidemiology, mechanisms, management, and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and the risk of CKD, establishing a framework for early prevention and management of these two common and interconnected diseases.
HEPATOBILIARY SURGERY AND NUTRITION
(2023)
Article
Gastroenterology & Hepatology
Andre Lopes Simao, Carolina Santos Palma, Laura Izquierdo-Sanchez, Antonella Putignano, Angela Carvalho-Gomes, Andreas Posch, Paola Zanaga, Irina Girleanu, Mariana Moura Henrique, Carlos Araujo, Delphine Degre, Thierry Gustot, Ivan Sahuco, Elia Spagnolo, Sofia Carvalhana, Miguel Moura, Diogo A. E. Fernandes, Jesus M. Banales, Manuel Romero-Gomez, Anca Trifan, Francesco Paolo Russo, Rudolf Stauber, Marina Berenguer, Christophe Moreno, Joao Goncalves, Helena Cortez-Pinto, Rui E. Castro
Summary: This study assessed the immune response and efficacy of COVID-19 vaccines in patients with chronic liver disease. The findings suggest that patients with liver disease have a weaker immune response to the vaccines, and there is no significant association between immune parameters and viral infection rates or vaccine efficacy. Age, cirrhosis, and vaccine type were found to influence the immune response.
Editorial Material
Gastroenterology & Hepatology
Manuel Romero-Gomez, Matthew J. J. Armstrong, Jesus Funuyet-Salas, Kamal Kant Mangla, Steen Ladelund, Anne-Sophie Sejling, Ichhya Shrestha, Arun J. J. Sanyal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Cell Biology
Kang Zheng, Fengjie Hao, Sandra Medrano-Garcia, Chaobo Chen, Feifei Guo, Laura Moran-Blanco, Sandra Rodriguez-Perales, Raul Torres-Ruiz, Maria Isabel Peligros, Javier Vaquero, Rafael Banares, Manuel Gomez del Moral, Jose R. Regueiro, Eduardo Martinez-Naves, Mohamed Ramadan Mohamed, Rocio Gallego-Duran, Douglas Maya, Javier Ampuero, Manuel Romero-Gomez, Albert Gilbert-Ramos, Sergi Guixe-Muntet, Anabel Fernandez-Iglesias, Jordi Gracia-Sancho, Mar Coll, Isabel Graupera, Pere Gines, Andreea Ciudin, Jesus Rivera-Esteban, Juan M. Pericas, Maria Dolores Frutos, Bruno Ramos Molina, Jose Maria Herranz, Matias A. Avila, Yulia A. Nevzorova, Edgar Fernandez-Malave, Francisco Javier Cubero
Summary: Progressive hepatic damage and fibrosis in chronic liver diseases can be controlled by N-RAS through downregulation of signaling pathways leading to hepatocyte necroptosis. This study suggests that N-RAS may have potential as a prognostic biomarker and therapeutic target for chronic liver diseases.
CELL DEATH & DISEASE
(2023)
Article
Gastroenterology & Hepatology
Carmen Lara Romero, Jia-Xu Liang, Isabel Fernandez-Lizaranzu, Javier Ampuero Herrojo, Javier Castell, Carmen del Prado Alba, Inmaculada Dominguez Pascual, Manuel Romero-Gomez
Summary: The objective of this study was to evaluate the performance of magnetic resonance elastography (MRE) in staging liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). The results showed that MRE is an effective and non-invasive method for detecting and staging liver fibrosis in NAFLD patients.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
(2023)
Article
Gastroenterology & Hepatology
Javier Crespo, Joaquin Cabezas, Antonio Aguilera, Agustin Albillos, Maria Buti, Jose Luis Calleja, Jorge Calvo Montes, Marta Casado Martin, Moises Diago, Conrado M. Fernandez Rodriguez, Inmaculada Fernandez Vazquez, Xavier Forns, Federico Garcia, Javier Garcia-Samaniego, Manuel Hernandez-Guerra de Aguilar, Francisco Jorquera, Jeffrey Lazarus, Sabela Lens, Elisa Martro, Jose Maria Molero Garcia, Maria Jose Pena Lopez, Juan Antonio Pineda, Manuel Rodriguez, Manuel Romero-Gomez, Gloria Sanchez Antolin, Miguel A. Serra Desfilis, Juan Turnes
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
(2023)